In May 2022, Yael Shiloh-Malawsky, MD, a neurologist at the UNC School of Medicine, met two new patients combatting a rare and fatal neurodegenerative disorder called Batten disease. With help from UNC, the twin girls were able to get personalized treatment from bench to bedside in record time.

The UNC site lead investigators are Edwin Kim, MD, associate professor of medicine, division chief of UNC Pediatric Allergy & Immunology, and Corinne Keet, MD, PhD, professor of pediatrics, vice chair of clinical and translational research.

This year’s match results show that only 91.8% of pediatric residency slots were successfully filled by programs compared to a higher percentage in years past. This ongoing outcome has many physicians in the field worried about the declining interest in pediatric subspecialties. Katherine Jordan, MD, and Priyanka Rao, MD, at the UNC School of Medicine wrote a JAMA perspective piece asking, “Where are all the pediatricians?”

After a thorough systematic analysis, Micheal Sandbank, PhD, at the UNC School of Medicine and other researchers across the United States found that evidence was lacking that higher intensity interventions provided increased benefits for young autistic children.

This five-year grant from the National Institute of Allergy and Infectious Diseases is led by Toni Darville, MD, director of the UNC Children’s Research Institute, in collaboration with scientists at Vaxcyte, Inc. and the University of Chicago.

UNC Children's hosted the UNC-Dunkin' Prom for teen patients on Friday, April 12. The night was filled with teens walking the red carpet and dancing the night away!

The University of North Carolina at Chapel Hill was one of four academic medical centers on the study, which shows that an intervention program developed by the American Academy of Pediatrics can dramatically reduce injuries in young children.

The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.

A woman with blonde hair and a white lab coat stands with hands in her pockets

A research study named Early Check has screened 1,000 newborns after birth in an effort to help identify rare conditions early, provide treatment, give parents educational information, and connect families with specialists throughout the state of North Carolina.

Stage one results from the OUtMATCH clinical trial, published in the New England Journal of Medicine, show that a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as age one could consume without an allergic reaction. Edwin Kim, MD, Corinne Keet, MD, PhD, and Mike Kulis, PhD, are contributing authors.

Sydney and Sheridan Taylor of Durham, North Carolina, have lived with this rare genetic disorder all of their lives. They and their mother, Helena, recount how far they have come since her daughters became patients at UNC Hospitals more than two decades ago and what more needs to be done during pain crises and emergency visits.

Catalina Berenblum Tobi, a 4th-year medical student, and Mara Buchbinder, PhD, professor and vice chair of social medicine, published qualitative research outlining how metaphors used when explaining inflammatory bowel disease affect young patients’ perceptions of illness and healing.

Tag: Pediatrics

UNC Fast-Tracks Personalized Treatment for Twins with Ultra Rare Genetic Disorder

UNC School of Medicine Selected as Site for New Food Allergy Research

Disinterest in Pediatric Care? Jordan and Rao Pen Perspective Piece on Pediatric Workforce Decline

New Study Suggests Higher Amounts of Intervention May Not Be More Helpful for Children on the Autism Spectrum

UNC School of Medicine Leads $9.3-Million Study to Create Chlamydia Vaccine

UNC Children’s Dunkin’ Prom

Researchers Show Injury Prevention Program Reduces Injuries in Young Children

How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis

A Newborn Genetic Screening Study Reaches New Milestone

Drug in OUtMATCH Clinical Trial FDA-Approved for the Reduction of Allergic Reactions from Accidental Food Exposures

How Two Sisters Continue to Soar with Sickle Cell Disease

Medical Student and Professor with Inflammatory Bowel Disease Join Forces to Help Pediatricians Understand the Power of Words